Enavate's Zenas Pharma Footnote: Obexelimab Pipeline Watch
Inside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
Identify rewards credit cards that are easier to qualify for, making your application process smoother. Find your perfect match today!
21,765 articlesInside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
March's trading session brought a noticeable shift as airline stocks rallied amid easing fuel concerns. This piece br...
Delek US shares jumped as crude and refining margins strengthened. This article breaks down the drivers, the risks, a...
Policy makers and tech leaders converge to treat China as a shared risk in AI leadership, signaling potential shifts ...
Big funds sometimes trim stakes in the market's most valuable names. This article breaks down why institutional inves...
A rough week for stocks left many investors wonder what comes next. This guide breaks down why the Dow tumbled and th...
Lineage (Line) 2026 earnings analysis dives into Q1 results, margin trends, and management’s guidance. Learn what the...
A fresh, investor-ready look at StoneX's Q2 2026 results. This article breaks down the key numbers, what they mean fo...
A single month brought a sharp rally for Sirius XM as two big catalysts emerged: a new YouTube partnership expanding ...
Global oil inventories are shrinking at a record pace as wartime disruption around Iran tightens supply from the Pers...
SpaceX IPO excitement can tempt any investor, but the space sector is risky and competitive. This guide compares Spac...
A new White House mascot, meet ‘coalie,’ anime-style anthropomorphic coal, is shaping how investors view energy polic...